Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiopathic pulmonary fibrosis

O P Sharma

    Current Opinion in Pulmonary Medicine
    |September 1, 1996
    PubMed
    Summary

    Idiopathic pulmonary fibrosis (IPF) is a complex lung disorder with unknown causes. Current treatments for IPF often lead to dissatisfaction and failure, highlighting the need for better therapeutic strategies.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Can I Interview Her? Gatekeeping in a Telephone Survey of Female Migrants in India.

    Survey practice·2025
    Same author

    An Indian Consensus on Sarcopenia: Epidemiology, Etiology, Clinical Impact, Screening, and Therapeutic Approaches.

    International journal of general medicine·2025
    Same author

    Gone and Forgotten? Predictors of Birth History Omissions in India.

    Demographic research·2024
    Same author

    Tuberculosis in elderly persons.

    The Indian journal of tuberculosis·2022
    Same author

    Diagnoses and management of adult cough: An Indian Environmental Medical Association (EMA) position paper.

    Respiratory medicine·2020
    Same author

    First Report on Association of Colletotrichum coccodes with Chili Anthracnose in India.

    Plant disease·2019

    Area of Science:

    • Pulmonology
    • Interstitial Lung Diseases

    Background:

    • Idiopathic pulmonary fibrosis (IPF), also known as cryptogenic fibrosing alveolitis in Europe, is a challenging respiratory condition.
    • The etiology of IPF remains largely unknown, contributing to treatment difficulties.

    Discussion:

    • Treatment for IPF is frequently met with patient dissatisfaction and therapeutic failure.
    • The complexity of IPF necessitates a more directed approach to management.

    Key Insights:

    • The unknown cause of IPF presents a significant barrier to effective treatment.
    • Current therapeutic strategies for IPF are often inadequate, leading to poor outcomes.

    Outlook:

    • Further research is crucial to elucidate the pathogenesis of IPF.
    • Development of novel and effective treatments for IPF is a critical unmet need.